The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Genetic causes of resistance to entinostat in luminal breast cancer model systems.
 
Maki Tanioka
No Relationships to Disclose
 
Joe Garay
No Relationships to Disclose
 
Cheng Fan
No Relationships to Disclose
 
Lisa A. Carey
Research Funding - Genentech/Roche (Inst); GlaxoSmithKline (Inst)
 
Charles M. Perou
Leadership - Bioclassifier; GeneCentric
Stock and Other Ownership Interests - Bioclassifier; GeneCentric
Consulting or Advisory Role - Bioclassifier; G1 Therapeutics; GeneCentric
Patents, Royalties, Other Intellectual Property - royalties from PAM50 breast cancer gene patent application, and from lung gene signature patent